Fertility Program
Fertility is a complex biological process that depends on the interaction between the reproductive system, hormonal function, general health, and several other factors affecting both partners.
When pregnancy does not occur after a period of regular unprotected intercourse, a comprehensive fertility evaluation can help identify potential causes and guide the appropriate treatment approach.
Infertility is generally defined as the inability to achieve pregnancy after 12 months or more of regular unprotected intercourse. Evaluation may be recommended earlier when there are known risk factors or medical conditions that could affect reproductive function. Fertility challenges may involve female factors, male factors, both partners, or remain unexplained despite appropriate evaluation.
For this reason, fertility care should not rely on a single treatment. It should begin with an accurate medical assessment followed by an individualized management plan.
What Does a Fertility Evaluation Include?
A fertility assessment aims to identify medical, hormonal, anatomical, and reproductive factors that may influence the ability to conceive.
Depending on the individual case, evaluation may include:
- Medical and reproductive history.
- Assessment of menstrual cycle and ovulation.
- Evaluation of ovarian reserve when clinically indicated.
- Assessment of the uterus and ovaries.
- Evaluation of fallopian tube patency when appropriate.
- Semen analysis and assessment of male reproductive health.
- Relevant hormonal testing.
- Ultrasound and other imaging studies when necessary.
- Evaluation of medical conditions or medications that may affect fertility.
Clinical guidelines recommend evaluating both partners when appropriate, rather than focusing exclusively on the female partner.
What Can Cause Fertility Problems?
Fertility challenges can result from a wide range of factors.
Female Factors
These may include:
- Ovulatory disorders.
- Polycystic ovary syndrome (PCOS).
- Reduced ovarian reserve.
- Fallopian tube disorders or blockage.
- Endometriosis.
- Uterine fibroids and other uterine abnormalities.
- Hormonal disorders.
Male Factors
Male fertility factors may include:
- Low sperm concentration.
- Reduced sperm motility.
- Abnormal sperm morphology.
- Hormonal disorders.
- Problems affecting sperm production or delivery.
- Certain genetic or medical conditions.
In some couples, more than one factor may be present, while in other cases, no specific cause can be identified despite appropriate testing.
An Individualized Fertility Treatment Plan
Following the initial assessment, the appropriate treatment pathway is determined according to the underlying cause, age, general health, reproductive history, and fertility goals.
Depending on the patient’s needs, treatment may include:
- Ovulation regulation or induction.
- Management of hormonal disorders.
- Surgical treatment of certain anatomical conditions.
- Intrauterine insemination (IUI).
- Assisted reproductive technologies such as In Vitro Fertilization (IVF).
- Intracytoplasmic Sperm Injection (ICSI) when clinically indicated.
- Egg, sperm, or embryo cryopreservation.
- Lifestyle interventions that may support reproductive health.
- Ongoing monitoring throughout treatment.
The World Health Organization recognizes fertility care as including prevention, diagnosis, and treatment, ranging from basic medical interventions to assisted reproductive technologies such as IVF when appropriate.
Fertility Preservation
Fertility care is not limited to treating infertility. Fertility preservation can also be an important part of reproductive medicine for selected patients.
Preservation may be considered for individuals who are expected to undergo medical treatments that could affect reproductive function or who have medical conditions that may compromise future fertility.
Depending on the clinical situation, options may include:
- Egg freezing.
- Sperm cryopreservation.
- Embryo cryopreservation.
- Selected fertility-preservation techniques involving reproductive tissue.
The appropriate preservation strategy depends on factors such as age, reproductive status, medical condition, and the anticipated impact of treatment.
Regenerative Medicine and Fertility
Regenerative medicine is an emerging field being investigated in reproductive medicine. Researchers are studying the potential role of cellular therapies, stem cells, growth factors, and tissue-based approaches in conditions affecting reproductive function.
These areas of research aim to better understand how cellular and molecular mechanisms may influence reproductive tissues and their biological environment.
However, it is important to distinguish experimental regenerative approaches from established fertility treatments. Stem cell-based interventions should not be presented as proven replacements for established fertility treatments such as IVF or other evidence-based reproductive interventions.
Any regenerative approach should be considered within an appropriate medical and ethical framework and according to the available scientific evidence.
Regen's Approach to Fertility Care
At Regen, the fertility program follows an individualized approach that begins with a comprehensive medical assessment before treatment options are considered.
Depending on the patient’s needs, the program may include:
- Fertility assessment for both partners.
- Review of medical and reproductive history.
- Appropriate laboratory and diagnostic investigations.
- Hormonal and reproductive assessment.
- Development of an individualized treatment pathway.
- Fertility-preservation planning when indicated.
- Coordination with gynecology, andrology, and assisted-reproduction specialists.
- Monitoring of treatment response.
- Discussion of emerging medical options according to current scientific evidence.
The goal is to identify the contributing factors first and then select the most appropriate treatment strategy rather than applying the same intervention to every patient.
When Should Fertility Evaluation Begin?
In general, fertility evaluation is recommended after 12 months of trying to conceive for women under 35, and after 6 months for women aged 35 or older.
For women over 40, earlier evaluation may be appropriate. Assessment may also be recommended sooner when there is a history of irregular or absent menstrual cycles, suspected reproductive disorders, known male-factor infertility, or previous medical treatment that may affect reproductive function.
Early evaluation can help identify potentially treatable factors and prevent unnecessary delays in accessing appropriate fertility care.
What Does Current Research and Guidance Say?
Current fertility guidelines emphasize a systematic and comprehensive evaluation of both partners.
The World Health Organization reports that infertility can affect people of reproductive age worldwide and may result from female factors, male factors, combined factors, or unexplained causes. Fertility care therefore encompasses a broad range of diagnostic and therapeutic approaches, from basic interventions to assisted reproductive technologies.
Fertility preservation has also become an increasingly important component of modern reproductive medicine, particularly for individuals at risk of losing reproductive function because of certain diseases or medical treatments.
At the same time, emerging regenerative approaches remain an area of active research and should be evaluated carefully according to the strength of available clinical evidence.